| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Modeling and comparison of dissolution profiles | European Journal of Pharmaceutical Sciences | 2001 | 4,227 |
| 2 | Nanosizing: a formulation approach for poorly-water-soluble compounds | European Journal of Pharmaceutical Sciences | 2003 | 1,109 |
| 3 | Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system | European Journal of Pharmaceutical Sciences | 2006 | 1,016 |
| 4 | Novel mechanisms and devices to enable successful transdermal drug delivery | European Journal of Pharmaceutical Sciences | 2001 | 993 |
| 5 | Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems | European Journal of Pharmaceutical Sciences | 2000 | 958 |
| 6 | Multidrug resistance (MDR) in cancer | European Journal of Pharmaceutical Sciences | 2000 | 943 |
| 7 | Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer | European Journal of Pharmaceutical Sciences | 2009 | 821 |
| 8 | Transport of drugs from the nasal cavity to the central nervous system | European Journal of Pharmaceutical Sciences | 2000 | 776 |
| 9 | Drug targeting | European Journal of Pharmaceutical Sciences | 2000 | 659 |
| 10 | A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics | European Journal of Pharmaceutical Sciences | 2013 | 651 |
| 11 | Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles | European Journal of Pharmaceutical Sciences | 2005 | 574 |
| 12 | Pharmacological properties of the ubiquitous natural product betulin | European Journal of Pharmaceutical Sciences | 2006 | 566 |
| 13 | Gene delivery by lipoplexes and polyplexes | European Journal of Pharmaceutical Sciences | 2010 | 550 |
| 14 | The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability | European Journal of Pharmaceutical Sciences | 2004 | 535 |
| 15 | Liposomes and skin: From drug delivery to model membranes | European Journal of Pharmaceutical Sciences | 2008 | 533 |
| 16 | Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4′-chlorophenyl)thiazol-2-yl] thiosemicarbazide | European Journal of Pharmaceutical Sciences | 1999 | 494 |
| 17 | In vitro–in vivo correlations for lipophilic, poorly water-soluble drugs | European Journal of Pharmaceutical Sciences | 2000 | 486 |
| 18 | Indoles — A promising scaffold for drug development | European Journal of Pharmaceutical Sciences | 2016 | 485 |
| 19 | Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells | European Journal of Pharmaceutical Sciences | 2000 | 482 |
| 20 | Transporters as a determinant of drug clearance and tissue distribution | European Journal of Pharmaceutical Sciences | 2006 | 474 |
| 21 | Dendrimers: Emerging polymers for drug-delivery systems | European Journal of Pharmaceutical Sciences | 2009 | 465 |
| 22 | Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? | European Journal of Pharmaceutical Sciences | 2012 | 461 |
| 23 | The applications of Vitamin E TPGS in drug delivery | European Journal of Pharmaceutical Sciences | 2013 | 450 |
| 24 | Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation | European Journal of Pharmaceutical Sciences | 2001 | 446 |
| 25 | Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing | European Journal of Pharmaceutical Sciences | 2015 | 444 |
| 26 | Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers | European Journal of Pharmaceutical Sciences | 2002 | 443 |
| 27 | When poor solubility becomes an issue: From early stage to proof of concept | European Journal of Pharmaceutical Sciences | 2007 | 433 |
| 28 | Microencapsulated chitosan nanoparticles for lung protein delivery | European Journal of Pharmaceutical Sciences | 2005 | 420 |
| 29 | Recent advances in polymeric micelles for anti-cancer drug delivery | European Journal of Pharmaceutical Sciences | 2016 | 403 |
| 30 | Chitosan and its derivatives in mucosal drug and vaccine delivery | European Journal of Pharmaceutical Sciences | 2001 | 400 |
| 31 | In vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: Effect of MePEG molecular weight and particle size | European Journal of Pharmaceutical Sciences | 2006 | 394 |
| 32 | VolSurf: a new tool for the pharmacokinetic optimization of lead compounds | European Journal of Pharmaceutical Sciences | 2000 | 387 |
| 33 | Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25 | European Journal of Pharmaceutical Sciences | 2001 | 373 |
| 34 | Microneedles for intradermal and transdermal drug delivery | European Journal of Pharmaceutical Sciences | 2013 | 349 |
| 35 | Strategy for effective brain drug delivery | European Journal of Pharmaceutical Sciences | 2010 | 344 |
| 36 | Lipid-based formulations for intestinal lymphatic delivery | European Journal of Pharmaceutical Sciences | 2002 | 332 |
| 37 | Regional levels of drug transporters along the human intestinal tract: Co-expression of ABC and SLC transporters and comparison with Caco-2 cells | European Journal of Pharmaceutical Sciences | 2006 | 327 |
| 38 | Enhanced oral paclitaxel absorption with vitamin E-TPGS: Effect on solubility and permeability in vitro, in situ and in vivo | European Journal of Pharmaceutical Sciences | 2005 | 326 |
| 39 | Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting | European Journal of Pharmaceutical Sciences | 2012 | 317 |
| 40 | In vitro models for the prediction of in vivo performance of oral dosage forms | European Journal of Pharmaceutical Sciences | 2014 | 306 |
| 41 | Establishment and functional characterization of an in vitro model of the blood–brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes | European Journal of Pharmaceutical Sciences | 2001 | 301 |
| 42 | PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release | European Journal of Pharmaceutical Sciences | 2002 | 300 |
| 43 | Eudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen | European Journal of Pharmaceutical Sciences | 2002 | 300 |
| 44 | Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight | European Journal of Pharmaceutical Sciences | 1998 | 298 |
| 45 | Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts | European Journal of Pharmaceutical Sciences | 2014 | 294 |
| 46 | Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2 | European Journal of Pharmaceutical Sciences | 2008 | 293 |
| 47 | Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine | European Journal of Pharmaceutical Sciences | 2000 | 289 |
| 48 | Structure–activity relationship of P-glycoprotein substrates and modifiers | European Journal of Pharmaceutical Sciences | 2000 | 284 |
| 49 | Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium | European Journal of Pharmaceutical Sciences | 2005 | 281 |
| 50 | Autophagy as a molecular target for cancer treatment | European Journal of Pharmaceutical Sciences | 2019 | 280 |
